What is it about?
We conducted a prospective, randomized, controlled trial to test whether the use of the ONQ Pain Buster can reduce pain after cardiac surgery in pediatric patients. The use of the ONQ Pain Buster to infuse 0.25% bupivacaine into the incision over the course of two to three days reduced the need for adjuvant pain medication, such as morphine, ketorolac, midazolam, and lorazepam. It was also safe.
Featured Image
Why is it important?
Reducing pain in children is important, particularly pediatric cardiac patients. This treatment is effective and safe for this purpose.
Perspectives
Reducing pain after surgery, without deleterious side effects, is critical in the pediatric population. The ONQ Pain Buster was effective and safe in reducing pain after pediatric cardiac surgery.
Dr. Christopher F Tirotta
Nicklaus Children's Hospital
Read the Original
This page is a summary of: Authorâs reply, Pediatric Anesthesia, January 2010, Wiley,
DOI: 10.1111/j.1460-9592.2009.03200.x.
You can read the full text:
Contributors
The following have contributed to this page
